Synchronous papillary and medullary thyroid carcinoma: about a case
Abstract
The synchronous existence of papillary and medullary carcinoma is infrequent, and they can have a discrete or mixed presentation. About its pathogenesis, it is not entirely clear, however, various theories have currently been proposed where genetic mutations and local and environmental factors involved in its appearance are involved. According to their histological characteristics, these are highly variable, presenting different structural patterns. The therapeutic approach differs in both histopathological types, so it is important to know about the synchronous existence of these tumors.
Downloads
References
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebeloet M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. doi: 10.1002/ijc.29210.
La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136(9):2187-95. doi: 10.1002/ijc.29251.
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, et al. Cancer Incidence in Five Continents. Geneva: International Agency for Research on Cancer; 2021.
Katoh H, Yamashita K, Enomoto T, Watanabe M. Classification and general considerations of thyroid cancer. Ann Clin Pathol. 2015;3(1):1045. doi: 10.47739/2373-9282/1045.
Surveillance, Epidemiology, and End Results Program, National Cancer Institute. Cancer Stat Facts: Thyroid Cancer [Internet]. Bethesda, MD: NCI; 2023 [citado el 13 de agosto del 2023]. Disponible en: https://seer.cancer.gov/statfacts/html/thyro.html
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Thyroid Carcinoma [Internet]. Version 1.2020. Plymouth Meeting, PA; NCCN 2020; [citado el 13 de agosto del 2023]. Disponible en: http://www.nccn.org/
Yao J, Li CF, Wang JJ, Zhang SY, Li YL, Yang J, et al. Medullary thyroid carcinoma combined with papillary thyroid carcinoma: case report and literature review. Int J Clin Exp Pathol. 2020;13(10):2710-17.
Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(12):1856-1883. doi: 10.1093/annonc/mdz400.
Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. American Association of Clinical Endocrinologists, American College
of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules--2016 update. Endocr Pract. 2016;22(5):622-39. doi: 10.4158/EP161208.GL.
WongKS,BarlettaJA.Thyroidtumorsyoudon’twanttomiss.Surg Pathol Clin. 2019;12(4):901-19. doi: 10.1016/j.path.2019.08.008.
Ciampi R, Romei C, Pieruzzi L, Tacito A, Molinaro E, Agate L, et al. Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland. J Endocrinol Invest. 2017;40(1):55-62. doi: 10.1007/s40618-016-0526-5.
Cracolici V, Mujacic I, Kadri S, Alikhan M, Niu N, Segal JP, et al. Synchronous and metastatic papillary and follicular thyroid carcinomas with unique molecular signatures. Endocr Pathol. 2018;29(1):9-14. doi: 10.1007/s12022-017-9491-6.
Laberiano-Fernández C, Somocurcio-Peralta J. Carcinoma papilar y medular de tiroides simultáneo. Rev Cuerpo Méd HNAAA. 2015;8(4):2262-30. doi: 10.35434/rcmhnaaa.2015.84.163.
Nangue C, Bron L, Portmann L, Volante M, Ris HB, Monnier P, et al. Mixed medullary-papillary carcinoma of the thyroid: Report of a case and review of the literature. Head Neck. 2009;31(7):968-74. doi: 10.1002/hed.20984.
1.png)
.png){kind=logo}
